Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alcon Inc. stock logo
ALC
Alcon
$79.95
-1.0%
$82.72
$69.44
$88.23
$39.42B0.91901,069 shs351,415 shs
Augmedix, Inc. stock logo
AUGX
Augmedix
$2.89
+1.8%
$3.95
$2.62
$6.25
$140.86M-0.16366,609 shs176,132 shs
ZMD
ZoomMed
C$0.02
+∞
C$0.02
C$0.01
C$0.05
C$2.03MN/A290,486 shs220,000 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alcon Inc. stock logo
ALC
Alcon
+0.17%+1.44%-3.41%+5.51%+10.19%
Augmedix, Inc. stock logo
AUGX
Augmedix
-5.02%-17.68%-28.28%-39.57%+283,999,900.00%
ZMD
ZoomMed
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alcon Inc. stock logo
ALC
Alcon
2.703 of 5 stars
3.32.00.80.01.20.82.5
Augmedix, Inc. stock logo
AUGX
Augmedix
1.8954 of 5 stars
3.53.00.00.00.73.30.0
ZMD
ZoomMed
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alcon Inc. stock logo
ALC
Alcon
2.64
Moderate Buy$91.2214.10% Upside
Augmedix, Inc. stock logo
AUGX
Augmedix
3.00
Buy$5.1778.78% Upside
ZMD
ZoomMed
N/AN/AN/AN/A

Current Analyst Ratings

Latest ZMD, 1ST, ALC, and AUGX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Alcon Inc. stock logo
ALC
Alcon
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$95.00 ➝ $95.00
4/10/2024
Alcon Inc. stock logo
ALC
Alcon
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$100.00
4/9/2024
Augmedix, Inc. stock logo
AUGX
Augmedix
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeIn-Line ➝ Outperform$4.50 ➝ $5.00
4/3/2024
Augmedix, Inc. stock logo
AUGX
Augmedix
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$5.50
3/19/2024
Augmedix, Inc. stock logo
AUGX
Augmedix
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$6.50 ➝ $4.50
3/19/2024
Augmedix, Inc. stock logo
AUGX
Augmedix
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$6.50 ➝ $5.00
3/14/2024
Alcon Inc. stock logo
ALC
Alcon
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSector Perform
3/13/2024
Alcon Inc. stock logo
ALC
Alcon
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$95.00
3/4/2024
Alcon Inc. stock logo
ALC
Alcon
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$90.00 ➝ $100.00
3/1/2024
Alcon Inc. stock logo
ALC
Alcon
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$92.00 ➝ $100.00
2/29/2024
Alcon Inc. stock logo
ALC
Alcon
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$87.00 ➝ $92.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alcon Inc. stock logo
ALC
Alcon
$9.46B4.17$5.20 per share15.37$41.83 per share1.91
Augmedix, Inc. stock logo
AUGX
Augmedix
$44.85M3.14N/AN/A$0.56 per share5.16
ZMD
ZoomMed
C$10K203.39N/AN/AC($0.02) per share-0.88

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alcon Inc. stock logo
ALC
Alcon
$974M$1.9640.7923.042.0610.30%6.75%4.63%5/14/2024 (Estimated)
Augmedix, Inc. stock logo
AUGX
Augmedix
-$19.17M-$0.45N/AN/A-42.74%-308.50%-41.57%5/10/2024 (Estimated)
ZMD
ZoomMed
N/A-C$0.01N/AN/AN/AN/AN/AN/A

Latest ZMD, 1ST, ALC, and AUGX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/18/2024Q4 2023
Augmedix, Inc. stock logo
AUGX
Augmedix
N/A-$0.09-$0.09-$0.09$12.30 million$12.68 million
2/27/2024Q4 2023
Alcon Inc. stock logo
ALC
Alcon
$0.68$0.70+$0.02$0.54$2.34 billion$2.33 billion  

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alcon Inc. stock logo
ALC
Alcon
N/AN/AN/AN/A4 Years
Augmedix, Inc. stock logo
AUGX
Augmedix
N/AN/AN/AN/AN/A
ZMD
ZoomMed
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alcon Inc. stock logo
ALC
Alcon
0.22
2.28
1.34
Augmedix, Inc. stock logo
AUGX
Augmedix
0.66
2.41
2.41
ZMD
ZoomMed
N/A
0.01
0.01

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Alcon Inc. stock logo
ALC
Alcon
53.86%
Augmedix, Inc. stock logo
AUGX
Augmedix
87.11%
ZMD
ZoomMed
N/A

Insider Ownership

CompanyInsider Ownership
Alcon Inc. stock logo
ALC
Alcon
N/A
Augmedix, Inc. stock logo
AUGX
Augmedix
10.97%
ZMD
ZoomMed
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Alcon Inc. stock logo
ALC
Alcon
25,000493.10 millionN/AOptionable
Augmedix, Inc. stock logo
AUGX
Augmedix
1,43048.74 million43.39 millionOptionable
ZMD
ZoomMed
N/A135.59 millionN/ANot Optionable

ZMD, 1ST, ALC, and AUGX Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Alcon logo

Alcon

NYSE:ALC
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Augmedix logo

Augmedix

NASDAQ:AUGX
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

ZoomMed

CVE:ZMD
ZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.